骨质疏松症
- 名osteoporosis
-
目的:观察阿法骨化醇治疗绝经后骨质疏松症的疗效。
Aim : to observe the clinical effects of alfacalcidol the treatment of postmenopausal osteoporosis .
-
目的观察肌注鲑鱼降钙素对并骨质疏松症的髋部骨折患者骨密度的影响。
Objective to assess the effects of salmon calcitonin on bone mineral density in osteoporosis patients with hip fracture .
-
大鼠骨质疏松症模型MDA、SOD的变化
The changes of MDA and SOD in rat models of osteoporosis
-
目的评价防治骨质疏松症药物1α(OH)-D3如何影响下颌骨的骨量变化。
Objective To evaluate the protecting effects of 1 α( OH ) - D 3 on mandibular bone loss .
-
SD大鼠骨性关节炎合并骨质疏松症模型的建立
Establishment of SD rat models of osteoarthritis and osteoporosis
-
ER基因多态性与中国南方妇女绝经后骨质疏松症的病例-对照研究
A case-control study on ER gene polymorphisms and postmenopausal osteoporosis in Southern Chinese women
-
低钙性笼养蛋鸡骨质疏松症PTH、CT及E2的变化
Changes of PTH , CT and E_2 in Cage layer Osteoporosis form Lower Calcium Dietary
-
骨质疏松症(Oste6porosis,缩写OP)被看作成为现代文明病。
Osteoporosis ( OP ) is regarded as modern civilization illness .
-
雌激素治疗去势雌性大鼠骨质疏松症血清NO、NOS的变化
Changes of serum NO and NOS in OVX rats model of osteoporosis after estrogen therapy
-
低频脉冲电磁场治疗骨质疏松症的Meta分析
A meta-analysis of pulsed electromagnetic fields for osteoporosis
-
适量补充钙和维生素D是防治骨质疏松症的基础措施&评新英格兰医学杂志Jackson等补充钙和维生素D与骨折危险一文
Adequate supplementation of calcium and vitamin D is the essential strategy for prevention and treatment of osteoporosis
-
骨质疏松症(OP)和糖尿病(DM)是两种常见的内分泌疾病,两者之间的相互关系引起了临床医生的极大兴趣。
Osteoporosis ( OP ) and diabetes mellitus ( DM ) are the most common diseases of endocrinology .
-
~(99m)Tc-MDP治疗骨质疏松症疗效评价
Efficacy of ~ ( 99m ) Tc-MDP in treatment of osteoporosis
-
目的:通过定量CT(QCT)检查,了解骨密度(BMD)的变化情况,以期对骨量减少及骨质疏松症(OP)的早期诊断和防治为临床提供帮助。
Purpose : Quantitative CT adjust bone mineral density measurement to be help for clinical diagnostic and prevention .
-
IL-4、IL-6、IL-10与其他骨代谢生化指标可辅助诊断骨质疏松症。
IL-4 , IL-6 and IL-10 and other bone metabolic markers may play a role in diagnosis of osteoporosis .
-
探讨降钙素在老年女性骨质疏松症发病中的作用,观察了雌、孕激素对雌性小鼠甲状腺C细胞的影响。
The effect of estrogen and progesterone on thyroid C cells in female mice was investigated in order to elucidate the role of Calcitonin ( CT ) in the pathogenesis of osteoporosis in old women .
-
骨质疏松症(Osteoporosis)是一种以低骨量和骨组织微结构破坏为特征,导致骨骼脆性增加和易发生骨折的全身性疾病。
As for Osteoporosis , its essential characters are low bone content and the destroyed micro-framework which can increase bone brittleness and easily fracture .
-
原发性骨质疏松症患者中轴骨IL6,bFGF的免疫组化
Immunohistochemistry Study of IL-6 and bFGF on Axial Bone in Primary Osteoporosis Cases
-
目的:骨质疏松症(Osteoporosis)是一种由于骨形成和骨吸收的负相平衡导致骨骼脆弱,并增加了骨折风险为特征的疾病。
Objective : Osteoporosis is a disease characterized by a decrease in bone mass leading to increased bone fragility and an increased risk of fracture .
-
老年女性糖尿病骨质疏松症VDR基因与血清BGP的变化
Changes of vitamin D receptor gene and serum BGP in diabetic patients with osteoporosis in old women
-
org/,检索1994-2006有关骨质疏松症和运动处方相关的论文,英文检索词为Exerciseprescription;osteoporosis,并限定语种为English;
Org / was conducted for articles related to osteoporosis and exercise prescription between 1994 and 2006 with the key words of " Exercise prescription ; Osteoporosis " in both Chinese and English .
-
结论胫骨超声速率(SOS)能够提供代谢性骨病的信息及骨强度的改变,对诊断代谢性骨病、骨质疏松症以及治疗前后骨密度的改变有一定的临床意义。
Conclusion The tibia values of SOS provides a meaningful diagnostic criteria of bone density and bone quality .
-
DXA、QCT和SPA方法测量47例绝经后妇女骨质疏松症的比较
A comparison of DXA , QCT and SPA for diagnosis of osteoporosis in postmenopausal women
-
方法:36只糖皮质激素性骨质疏松症大鼠随机分为成骨细胞培养上清液组(A组)、原始培养液组(B组)和对照组(C组),每组12只。
Method : Thirty-six male SD rats which was glucocorticoid-induced osteoporosis were randomly divided into 3 groups ( 12 rats for each group ): group A , given supernate of osteoblast 0.5ml/kg twice a week through intramuscular injection ;
-
高原去势大鼠骨质疏松症血清IL-6、TNF-α和尿DPD的变化观察
Changes of IL-6 and TNF - α in the serum and urine DPD of ovariectomized rats with osteoporosis at high altitude
-
结论ER基因RFLP与绝经后妇女BMD有关,此即为中国妇女绝经后骨质疏松症发病的原因。
Conclusion RFLP of ER gene associated with BMD in postmenopausal healthy women and this might explain the cause of postmenopausal osteoporosis in Chinese women .
-
目的观察重组人甲状旁腺激素(1-34)[RecombinantHumanParathyroidHormone(1-34),rh-PTH(1-34)]对糖皮质激素引起的大鼠继发性骨质疏松症(OP)的治疗作用。
Objective To investigate the therapeutic effect of recombinant human parathyroid hormone ( 1-34 ) [ rhPTH ( 1-34 ) ] on osteoporosis induced by glucocorticoid in rats .
-
本研究比较了双能X线吸法(DXA)与定量CT(QCT)在骨质疏松症诊断中的应用。
In this study we compared dual energy x-ray absorption ( DXA ) and quantitative computed tomography ( QCT ) in the diagnosis of osteoporosis .
-
结论:①eNOS依赖性NO的低表达是糖皮质激素性骨质疏松症的一个重要发病机制。
Conclusion : ① It demonstrates that the lower expression of nitric oxide depended on eNOS is an important pathogenesis of glucocorticoid-induced osteoporosis .
-
作者认为:PVP可有效地解除椎体肿瘤或骨质疏松症椎体压缩性骨折患者的痛苦,提高和改善生活质量,延长生存时间,为一技术操作较简单和实用性极强的介入技术。
The author concludes that PVP is effective for pain relief and improvement of quality of life in benign and malignant vertebral tumors , and osteoporotic vertebral fractures .